News

monday.com (MNDY) Poised for Earnings Surge in Q3 2024

monday.com (MNDY) Poised for Earnings Surge in Q3 2024

monday.com (MNDY) Earnings Anticipation

monday.com Ltd. (NASDAQ: MNDY) is gearing up to release its third quarter earnings results shortly. This anticipation has sparked interest among investors and analysts alike as they eagerly await to see how the company has performed.

Projected Earnings for Q3

Industry analysts forecast that the company is set to report earnings of 88 cents per share for the quarter. This projection reflects an increase from the 85 cents per share recorded during the same period last year. Furthermore, monday.com’s quarterly revenue is expected to reach approximately $312.26 million, marking a significant rise from $251 million a year earlier.

Performance Review of Q2

On August 11, the company announced a remarkable 27% year-on-year growth in revenue, achieving $299.01 million for the second quarter. This figure surpassed market expectations, which were around $293.54 million, showcasing the company's robust performance.

Stock Movement and Market Sentiment

In response to its positive financial outlook, shares of monday.com saw a 4.7% increase, closing at $189.59. This upward movement reflects the market’s confidence in the company’s potential as it navigates through this financial period.

Analyst Insights on MNDY

With the upcoming earnings call, we should also consider the perspectives from analysts regarding monday.com’s stock. Let's take a closer look at how some of the most accurate analysts view the stock:

Wells Fargo’s Evaluation

Ryan Macwilliams from Wells Fargo has initiated coverage on the stock, giving it an Overweight rating with a price target of $260. Macwilliams boasts an accuracy rate of 60%, indicating a solid understanding of the stock’s potential.

Citigroup's Position

Steven Enders from Citigroup has also weighed in with a maintained Buy rating, increasing the price target from $326 to $332. Enders’ accuracy rate stands at an impressive 68%, reflecting confidence in the company’s trajectory.

Cantor Fitzgerald's Perspective

Thomas Blakey from Cantor Fitzgerald holds an Overweight rating, but has adjusted the price target downward from $286 to $257. With an accuracy rate of 69%, Blakey's revised expectations indicate a tempered but still positive outlook.

Piper Sandler's Review

Piper Sandler’s analyst Brent Bracelin has also maintained an Overweight rating while reducing the price target from $300 to $275. With an accuracy rate of 73%, Bracelin remains optimistic about the company's resilience.

Goldman Sachs Analysis

Kash Rangan from Goldman Sachs sustained a Buy rating but adjusted the price target down from $350 to $270. Rangan has an accuracy rate of 67%, showing ongoing faith in monday.com's long-term growth prospects.

Conclusion

If you're considering investing in MNDY, these insights from experienced analysts can guide your decision-making. Keep an eye on upcoming announcements, as they may significantly influence market perception and stock performance.

Frequently Asked Questions

What is monday.com’s expected earnings for Q3?

The company is anticipated to report earnings of 88 cents per share for Q3.

How much revenue is monday.com expected to generate?

Analysts project quarterly revenue to be around $312.26 million.

What was the revenue growth in Q2?

monday.com achieved a revenue growth of 27% year-on-year, totaling $299.01 million in Q2.

What has been the stock performance leading up to earnings?

The stock rose 4.7%, closing at $189.59 prior to earnings announcement.

What do analysts say about investing in MNDY?

Analysts maintain positive ratings, with several having raised their price targets, indicating confidence in the company's future.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 51

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 89

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 71

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 188

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading

Top 5 Most Recently Viewed Articles

Stocks Rebound in Volatile Trading After Major Sell-off

Updated Category Markets Views 525

Global Stocks See Slight Uptick Amid Market Volatility Tuesday saw global stocks climb, yet trading was erratic. Following Monday's forceful selloff, investors remained wary. Officials of central banks aimed at reassuring the markets. Some respite came from Tokyo overnight's 10% rebound in Nikkei. Investor mood was still wary, though. U.S. stock futures displayed mixed...

Continue Reading
Projecting the Growth of the Femtech Market Through 2031

Updated Category News Views 77

The Femtech market stood at an impressive USD 33.92 billion back in 2023, setting the stage for its remarkable leap to a projected value of USD 113.53 billion by 2031. That’s a compound annual growth rate (CAGR) of about 16.3%. So, what's fueling this explosion? For starters, it's all about the rising awareness surrounding women's health issues—a topic that finally...

Continue Reading
Vestis Corporation Class Action Lawsuit: Key Details to Know

Updated Category News Views 494

Class Action Lawsuit Against Vestis Corporation Pomerantz LLP is drawing attention to a class action lawsuit filed against Vestis Corporation (NYSE: VSTS) concerning allegations of securities fraud. Investors who have incurred losses due to their investment in Vestis are encouraged to take action. Deadline for Investors Investors have until August 8, 2025, to request the...

Continue Reading
Associated Banc-Corp Sets Public Offering for Growth Funding

Updated Category News Views 215

Associated Banc-Corp Announces Stock Offering Associated Banc-Corp (NYSE: ASB) has recently made headlines with its announcement regarding a public offering of its common stock. The company is set to offer 12 million shares, each with a par value of $0.01, at a price of $25.00 per share. This means the total gross proceeds from this offering are expected to reach an...

Continue Reading
Olaplex Holdings Inc. to Engage at Canaccord Genuity Growth Conference

Updated Category News Views 138

Olaplex Holdings Inc. to Engage at Canaccord Genuity Growth Conference Olaplex Holdings, Inc. (NASDAQ: OLPX) has recently confirmed its engagement in the Canaccord Genuity 45th Annual Growth Conference. This prestigious event is set to take place soon, where the company will have a platform to showcase its commitment to innovation in the beauty and hair care industry....

Continue Reading